The UNC Eshelman School of Pharmacy is a key member of the robust research arm of the University of North Carolina at Chapel Hill.

Our faculty are leaders and innovators in their areas of research, and the School’s proximity to the Research Triangle Park and other research campuses spurs collaboration and partnerships in academia and with industry. Research at the School has spawned a number of spin-off companies, and in 2009, the School led the University with twenty-six invention disclosures and four patents received.

If you are looking for opportunities for research collaboration, please visit the Global Engagement section of our website, or explore our Eshelman Institute for Innovation’s resources for entrepreneurial development.

A Unique Perspective

The UNC Eshelman School of Pharmacy provides a unique perspective among peer institutions in our approach to research. The School conducts a wide range of advanced research that aligns with five phases of the drug discovery, development and delivery cycle.

Each phase is represented by a division within the School. Faculty and graduate students alike are encouraged to work with their peers within the School and the University to further realize research goals in discovery, preclinical and clinical development of therapeutic agents, optimum delivery of drug therapy, evaluation of health and therapeutic outcomes of novel drug therapies and technologies, as well as regulatory policies.

Recent Research News

Stefanie Ferreri

Ferreri Awarded $3M CDC Grant for Study on Opioid Use

October 10, 2018

The Centers for Disease Control awarded a $3 million grant to Stefanie Ferreri, Pharm.D., for a study on screening older adults who use prescription opioids and are at risk for falls. Ferreri is the executive vice chair of the Division … Continued

Gonzalez Receives $2M NIH Grant for Project on Childhood Obesity

October 9, 2018

Daniel Gonzalez, Pharm.D., Ph.D., an assistant professor at the UNC Eshelman School of Pharmacy in the Division of Pharmacotherapy and Experimental Therapeutics, received a $2 million NIH Research Project Grant for research into a new treatment for childhood obesity. Gonzalez’s … Continued

Crona Awarded ACCP Research Institute Futures Grant

September 24, 2018

Daniel Crona, Pharm.D., Ph.D., an assistant professor at the UNC Eshelman School of Pharmacy in the Division of Pharmacotherapy and Experimental Therapeutics, was awarded the American College of Clinical Pharmacy Research Institute Futures Grant Junior Investigator Award. Crona received the … Continued


Read More